2025 -  WEEK 15

What's New in RWE Research this Week

  1. Safety profile of faricimab: a multi-source pharmacovigilance analysis using FAERS and JADER. Liu C, Li S, Wang Z, Li Z, Fang Z, Zhang Y, Gao Y.BMC Pharmacol Toxicol. 2025 Apr 12;26(1):82. doi: 10.1186/s40360-025-00902-6.PMID: 40221797

 

  1. Real-world study of cabozantinib treatment of advanced renal cell carcinoma in Taiwan. Tsai YC, Li JR, Chiu KY, Su PJ, Su YL, Chung HJ, Li CC, Huang CP, Guo JC, Chen CS, Chang I, Perrot V, Chang YH. J Formos Med Assoc. 2025 Apr 11:S0929-6646(25)00117-2. doi: 10.1016/j.jfma.2025.03.016. Online ahead of print.PMID: 40221295

 

  1. Impact of Chronic Total Occlusion PCI in Non-LAD Coronary Arteries on Patients with Cardiomyopathy. Megaly M, Zakhour S, Maki M, Albusoul L, Nakhle A, Karacsonyi J, Mashayekhi K, Rinfret S, Brilakis ES, Alaswad K.Am J Cardiol. 2025 Apr 10:S0002-9149(25)00235-8. doi: 10.1016/j.amjcard.2025.04.004. Online ahead of print.PMID: 40221124

 

  1. Considerations for Improving the Quality of Non-Hypothesis Evaluating Treatment Effectiveness Analyses using Real-World Data: Research Methods, Conduct, and Reporting. Barrette E, Crown WH, Hanisch M, Alfonso-Cristancho R, Sheth S, Z Gautier SC, Surinach A, Cziraky M, Morrow JD, Buikema AR.Value Health. 2025 Apr 10:S1098-3015(25)01967-9. doi: 10.1016/j.jval.2025.02.017. Online ahead of print.PMID: 40220865

 

  1. Use of alternative and confirmatory data in support of rare disease drug development. Chow SC, Pariser A, Galson S.J Biopharm Stat. 2025 Apr 11:1-15. doi: 10.1080/10543406.2025.2489279. Online ahead of print.PMID: 40219600

 

  1. Remdesivir associated with reduced mortality in hospitalized COVID-19 patients: treatment effectiveness using real-world data and natural language processing. Arribas López JR, Ruiz Seco MP, Fanjul F, Díaz Pollán B, González Ruano Pérez P, Ferre Beltrán A, De Miguel Buckley R, Portillo Horcajada L, De Álvaro Pérez C, Barroso Santos Carvalho PJ; Savana Research Group; Riera Jaume M.BMC Infect Dis. 2025 Apr 12;25(1):513. doi: 10.1186/s12879-025-10817-6.PMID: 40217145

 

  1. Antimicrobial prophylaxis with ampicillin/sulbactam versus cefazolin for orthopedic implant-related surgical site infections: A retrospective cohort study. Hatano M, Sasabuchi Y, Aso S, Yamada K, Ishikura H, Tanaka T, Tanaka S, Yasunaga H.J Orthop Sci. 2025 Apr 10:S0949-2658(25)00083-1. doi: 10.1016/j.jos.2025.03.010. Online ahead of print.PMID: 40216570

 

  1. Prospective external validation of the automated PIPRA multivariable prediction model for postoperative delirium on real-world data from a consecutive cohort of non-cardiac surgery inpatients. Reeve KA, Schmutz Gelsomino N, Venturini M, Buddeberg F, Zozman M, Stocker R, Kedda MA, Meier P, Möller M, Wildhaber SP, Dodsworth BT.BMJ Health Care Inform. 2025 Apr 10;32(1):e101291. doi: 10.1136/bmjhci-2024-101291.PMID: 40216453

 

  1. Viral suppression, viral failure and safety outcomes in children and adolescents living with HIV on dolutegravir in Europe and Thailand. Scott K, O'Rourke J, Jackson C, Ene L, Galli L, Goetghebuer T, Henegar C, Königs C, Marczyńska M, Naver L, Noguera-Julian A, Paioni P, Ramos JT, Smith B, Songtaweesin WN, Spoulou V, Tantawarak N, Turkova A, Vannappagari V, Volokha A, Bamford A, Castro H, Chappell E, Dalla Valle G, Foster C, Guillén Martín S, Prieto Tato LM, Puthanakit T, Sherstiuk H, Shkurka I, Soeria-Atmadja S, Judd A, Crichton S, Collins IJ.Clin Infect Dis. 2025 Apr 11:ciaf191. doi: 10.1093/cid/ciaf191. Online ahead of print.PMID: 40215206

 

  1. Cardiovascular events, mortality, and incident type 2 diabetes in patients with metabolic dysfunction-associated steatohepatitis: a claims-based analysis of commercial and medicare advantage enrollees. Gbadamosi SO, Swindle JP, Nguyen H, Li Q, Hoovler A.Expert Rev Pharmacoecon Outcomes Res. 2025 Apr 11. doi: 10.1080/14737167.2025.2490303. Online ahead of print.PMID: 40215125

 

  1. Does Neoadjuvant Chemotherapy Followed by Radical Cystectomy Improve the Survival of Muscle-Invasive Bladder Cancer in Real-World Clinical Practice?Naito R, Izumi K, Takimoto A, Nakagawa R, Kano H, Makino T, Iwamoto H, Yaegashi H, Kawaguchi S, Shigehara K, Nohara T, Mizokami A.Int J Urol. 2025 Apr 11. doi: 10.1111/iju.70064. Online ahead of print.PMID: 40213854

 

  1. Comparative Analysis of Leadless Versus Transvenous Pacemakers in Non-Heart Failure Patients: A Multicenter US Retrospective Study. Fouad M, Abdelsayed K, Tabassum S, Ellabban MH, Thangjui S, Abdelazeem B, Arora S.J Cardiovasc Electrophysiol. 2025 Apr 10. doi: 10.1111/jce.16672. Online ahead of print.PMID: 40211451

 

  1. MISTIC: a novel approach for metastasis classification in Italian electronic health records using transformers. Lilli L, Santoro M, Masiello V, Patarnello S, Tagliaferri L, Marazzi F, Capocchiano ND.BMC Med Inform Decis Mak. 2025 Apr 10;25(1):160. doi: 10.1186/s12911-025-02994-w.PMID: 40211241

 

  1. ATCodeR: a dictionary-based R-tool to standardize medication free-text. Schnorr I, Andreas S, Schumann L, Hahn S, Vehreschild JJ, Maier D.Sci Rep. 2025 Apr 10;15(1):12252. doi: 10.1038/s41598-025-97150-9.PMID: 40211013 Free article.

 

  1. Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: Where Are We Today? Bertelsen N, Oehrlein E, Lewis B, Westrich-Robertson T, Elliott J, Willgoss T, Swarup N, Sargeant I, Panda O, Marano MM, Chapman H, Brooke N.Ther Innov Regul Sci. 2025 Apr 10. doi: 10.1007/s43441-025-00770-6. Online ahead of print.PMID: 40210822

 

  1. Monthly Headaches and Severity in Patients on Galcanezumab or Traditional Preventive Migraine Medication: A 24-Month Claims and Electronic Health Records Study. Varnado OJ, Vu M, Kim G, Hoyt M, Buysman E, Nayyar A, Anand S, Viktrup L.Neurol Ther. 2025 Apr 11. doi: 10.1007/s40120-025-00742-w. Online ahead of print.PMID: 40210791

 

  1. Interobserver Agreement of the Eczema Area and Severity Index for Atopic Dermatitis Severity Assessment: A Real-World Evidence Villa-Gonzalez JM, Gonzalez-Hermosa MR, Ugedo Alzaga J, Pérez Blasco R, Andrés Ibarrola P, Atxutegi Ayesta X, García García A, Irizar Aguirre I, Udondo González Del Tánago B, Pascual Ares M, Allende Markixana I, Acebo Mariñas E, Díaz Ramón JL, Mendieta Eckert M, Navajas Pinedo B, Eizaguirre Uriarte X, Ocerin Guerra I, Agesta Sánchez N, Álvarez Sánchez S, Lasa Elgezua O, Santos-Zorrozúa B, Ratón Nieto JA.Dermatitis. 2025 Apr 10. doi: 10.1089/derm.2025.0054. Online ahead of print.PMID: 40208837

 

  1. Correction: Taxane/anthracycline combinations reduced incidence of breast cancer recurrence in young women across molecular subtypes: a real-world evidence of Taiwan from 2011 to 2019. Chien YN, Lin LY, Lin YC, Hsieh YC, Tu SH, Chiou HY.Breast Cancer Res Treat. 2025 Apr 10. doi: 10.1007/s10549-025-07691-w. Online ahead of print.PMID: 40208513 No abstract available.

 

  1. Reimagining optimization of clinical trials efficiency through use of statistical innovation, technology and non-standard data sources. Natarajan K, Alemayehu D.J Biopharm Stat. 2025 Apr 10:1-11. doi: 10.1080/10543406.2025.2489289. Online ahead of print.PMID: 40208096

 

  1. Clinical outcomes of maintenance therapy with sulfasalazine compared to 5-aminosalicylates in children with ulcerative colitis. Mansuri I, Wang S, Fishman L, Rufo PA, Liu E, Chan C, Bousvaros A.J Pediatr Gastroenterol Nutr. 2025 Apr 10. doi: 10.1002/jpn3.70041. Online ahead of print.PMID: 40205880

 

  1. Real-World Effectiveness and Safety of Mirikizumab Induction Therapy in Patients With Ulcerative Colitis: A Multicentre Retrospective Observational Study. Takagi Y, Sato T, Nishiguchi T, Nogami A, Igeta M, Yagi S, Ikenouchi M, Kawai M, Kamikozuru K, Yokoyama Y, Tomita T, Fukui H, Fukata M, Kobayashi T, Shinzaki S.Aliment Pharmacol Ther. 2025 Apr 9. doi: 10.1111/apt.70140. Online ahead of print.PMID: 40205711

 

  1. Associations between intercurrent events and cardiorenal clinical outcomes in non-diabetic chronic kidney disease: a real-world retrospective cohort study in the United States. Wanner C, Schuchhardt J, Bauer C, Brinker M, Frank Kleinjung, Vaitsiakhovich T.BMC Nephrol. 2025 Apr 9;26(1):184. doi: 10.1186/s12882-025-04021-6.PMID: 40205540 Free PMC article.

 

  1. Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group. Minarik J, Pour L, Latal V, Jelinek T, Straub J, Jungova A, Radocha J, Pavlicek P, Stork M, Pika T, Krhovska P, Popkova T, Sedlak F, Spicka I, Jindra P, Capounova V, Maisnar V, Hajek R.BMC Cancer. 2025 Apr 9;25(1):651. doi: 10.1186/s12885-025-14087-y.PMID: 40205357 Free PMC article.

 

  1. From Clinical Trials to Real-World Experiences: Evidence About Cefiderocol Use and Potential Role in Empirical Therapy. Russo A, Serapide F.Infect Dis Ther. 2025 Apr 9. doi: 10.1007/s40121-025-01147-w. Online ahead of print.PMID: 40205143 Review.

 

  1. One-class support vector machines for detecting population drift in deployed machine learning medical diagnostics. Jones WS, Farrow DJ.Sci Rep. 2025 Apr 9;15(1):12157. doi: 10.1038/s41598-025-94427-x.PMID: 40204747 Free PMC article.

 

  1. Biologic switch timing and risk of infection in patients with ulcerative colitis/Crohn's disease: a retrospective study. Kruger AJ, Dormont F, Capit N, Schilsky S, Roberts A, Lin Y, Badalamenti S, Wiekowski M, Bewtra M, Colombel JF.Clin Gastroenterol Hepatol. 2025 Apr 7:S1542-3565(25)00245-9. doi: 10.1016/j.cgh.2025.01.028. Online ahead of print.PMID: 40204205

 

  1. Understanding buprenorphine treatment for opioid use disorder in real-world data. Jarlenski M, Krans EE.Am J Obstet Gynecol. 2025 Apr 7:S0002-9378(25)00205-4. doi: 10.1016/j.ajog.2025.04.002. Online ahead of print.PMID: 40204178 No abstract available.

 

  1. Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR+/HER2- BC patients: results from the multicenter PALMARES-2 study. Provenzano L, Dieci MV, Curigliano G, Giuliano M, Botticelli A, Lambertini M, Rizzo G, Pedersini R, Sirico M, La Verde N, Gennari A, Zambelli A, Toss A, Piras M, Giordano M, Tagliaferri B, Generali D, Sartori D, Miliziano D, Menichetti A, Ligorio F, Zurlo C, Griguolo G, Berton Giachetti PP, Faso V, Corti C, Chiappe E, Scagnoli S, Pisegna S, Capasso C, De Angelis C, Arpino G, Criscitiello C, Guarneri V, Pruneri G, Mariani L, Vernieri C; PALMARES-2 study group.Ann Oncol. 2025 Apr 7:S0923-7534(25)00134-6. doi: 10.1016/j.annonc.2025.03.023. Online ahead of print.PMID: 40204155

 

  1. Integration of administrative claims and clinical data to advance real-world evidence generation in oncology. Nguyen C, Zheng H, Grabner M, Barron J, Dixon RW, Cziraky M, Sweet B, Hill N.Curr Med Res Opin. 2025 Apr 9:1-11. doi: 10.1080/03007995.2025.2482665. Online ahead of print.PMID: 40202297

 

  1. Effect of biological treatment in uncontrolled severe chronic rhinosinusitis with nasal polyps in Belgium: a multicentre real-world data Viskens AS, Bollens L, Borgers E, Halewyck S, Hox V, Jorissen M, Lemmens W, Rogister F, Speleman K, Van Gerven L, Vanderveken O, Verhaeghe B, Vroegop A, Martens K, Hellings PW.Rhinology. 2025 Apr 9. doi: 10.4193/Rhin24.509. Online ahead of print.PMID: 40202121

 

  1. Advances in endovascular thrombectomy for the treatment of acute ischemic stroke. Lauer D, Sulženko J, Malíková H, Štětkářová I, Widimský P.Expert Rev Neurother. 2025 Apr 9. doi: 10.1080/14737175.2025.2490538. Online ahead of print.PMID: 40200903 Review.

 

  1. Journey of Patients with Psoriasis in an Italian Tertiary Centre, an 11-year Retrospective Analysis. Ippoliti E, Falco GM, Di Giorgi N, Lenkowitz J, Chiricozzi A, Cannizzaro MV, Quattrini L, Caldarola G, De Simone C, D'Amore A, Peris K.Acta Derm Venereol. 2025 Apr 8;105:adv42503. doi: 10.2340/actadv.v105.42503.PMID: 40200596 Free article.

 

  1. The Digital Narrative: Chronic Pain Self-Management Insights from Reddit in Systemic Lupus Erythematosus. Bozkurt S, Walker A, Park T, Le N, Sarker A, Irani A, Falasinnu T.Stud Health Technol Inform. 2025 Apr 8;323:483-485. doi: 10.3233/SHTI250137.PMID: 40200534

 

  1. Predicting Prostate Cancer Diagnosis Using Machine Learning Analysis of Healthcare Utilization Patterns. Cui W, Halwani A, Li C, Finkelstein J.Stud Health Technol Inform. 2025 Apr 8;323:6-10. doi: 10.3233/SHTI250037.PMID: 40200434

 

  1. Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A systematic review and meta-analysis. Sureda A, Pavlovsky A, Haidar D, Kristo F, Stache V, Zomas A.Bone Marrow Transplant. 2025 Apr 8. doi: 10.1038/s41409-025-02557-7. Online ahead of print.PMID: 40200006

 

  1. Comprehensive analysis of prostate cancer life expectancy, loss of life expectancy, and healthcare expenditures: Taiwan national cohort study spanning 2008 to 2019. Liu PC, Lin YS, Ou YC, Hsu CY, Tung MC, Chiu YM.PLoS One. 2025 Apr 8;20(4):e0310613. doi: 10.1371/journal.pone.0310613. eCollection 2025.PMID: 40198602 Free PMC article.

 

  1. Burden of Glucocorticoid Use and Risk of Toxicities Among Patients with Immunoglobulin-G4-Related Disease: A Retrospective US-Based Claims Study. Wallace ZS, Park JY, Serra E, Gagnon-Sanschagrin P, Guérin A, Patterson K, Patel H, Singh VK.Rheumatol Ther. 2025 Apr 8. doi: 10.1007/s40744-025-00763-9. Online ahead of print.PMID: 40198545 Free article.

 

  1. Pharmacogenomics of chemotherapy induced peripheral neuropathy using an electronic health record-derived definition: a genome-wide association study. Jones MK, Nicklawsky A, Shortt J, Pattee J, Kennerley V, Eule CJ, Candelario N; Biobank at the Colorado Center for Personalized Medicine (Banner Authorship); O'Donnell PH, Flaig TW.Support Care Cancer. 2025 Apr 8;33(5):362. doi: 10.1007/s00520-025-09392-y.PMID: 40198382

 

  1. A review of the safety of sodium-glucose co-transporter-2 inhibitors. O'Hara DV, Jardine MJ.Diabetes Obes Metab. 2025 Apr 8. doi: 10.1111/dom.16385. Online ahead of print.PMID: 40197653 Review.

 

  1. The Impact of Cannabis Use in Gastroparesis: A Propensity Matched Analysis 41,374 gastroparesis patients. Kilani Y, Gonzalez Mosquera DA, Puelo PC, Aldiabat M, Ruffle JK, Mahmoud MY, Farmer AD. Am J Gastroenterol. 2025 Apr 8. doi: 10.14309/ajg.0000000000003479. Online ahead of print.PMID: 40197432

 

  1. Medication-related perceptions of children and adolescents with severe asthma and moderate-to-severe atopic dermatitis: a non-interventional exploratory study. Herzig M, Vom Hove M, Bertsche A, Lipek T, Kiess W, Bertsche T, Prenzel F, Neininger MP.Allergy Asthma Clin Immunol. 2025 Apr 7;21(1):16. doi: 10.1186/s13223-025-00961-8.PMID: 40197393 Free PMC article.

 

  1. Localized and diffuse tenosynovial giant cell tumor: real-world results from a patient observational registry. Stern S, McKenzie PF, Bernthal N, O'Neill S, Palmerini E, Randall RL, Tap W, Scharschmidt T, Rothschild S.Future Oncol. 2025 Apr 8:1-10. doi: 10.1080/14796694.2025.2488635. Online ahead of print.PMID: 40197108

 

  1. Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccine. Borrow R, Tomasi Cont L, Toneatto D, Bambini S, Bobde S, Sohn W-Y, Biolchi A, Masignani V, Beernink PT, Lattanzi M. 2025 Apr 8:e0089824. doi: 10.1128/msphere.00898-24. Online ahead of print.PMID: 40197090 Free article.Review.

 

  1. Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies. Thomsen RW, Mailhac A, Løhde JB, Pottegård A.Diabetes Obes Metab. 2025 Apr 8. doi: 10.1111/dom.16364. Online ahead of print.PMID: 40196933

 

  1. Peyronie's disease in the United States: A real-world, 13-year nationwide analysis of demographics, clinical characteristics, and treatment trends. Orsini A, Bologna E, Bignante G, Lasorsa F, Lambertini L, Biasatti A, Liguori G, Marchioni M, Porpiglia F, Lucarelli G, Schips L, Arcaniolo D, De Sio M, Cherullo EE, Autorino R, Manfredi C. 2025 Apr 7. doi: 10.1111/andr.70029. Online ahead of print.PMID: 40195592

 

  1. Safety assessment of apremilast: real-world adverse event analysis from the FAERS database. Ren L, Zhao K, Wang B, Xiao S, Liu J, Tu C.Arch Dermatol Res. 2025 Apr 7;317(1):684. doi: 10.1007/s00403-025-04193-z.PMID: 40195166

 

  1. Digital Health Platform for Maternal Health: Design, Recruitment Strategies, and Lessons Learned From the PowerMom Observational Cohort Study. Ajayi T, Kueper J, Ariniello L, Ho D, Delgado F, Beal M, Waalen J, Baca Motes K, Ramos E.JMIR Form Res. 2025 Apr 7;9:e70149. doi: 10.2196/70149.PMID: 40194282 Free article.

 

  1. Aromatase-inhibitors Treatment Alone or with GH Increases Final Height in Short-Statured Pubertal Boys - Real-World Data. Yackobovitch-Gavan M, Tenenbaum A, Phillip M, Lazar L, Oron T.J Clin Endocrinol Metab. 2025 Apr 7:dgaf224. doi: 10.1210/clinem/dgaf224. Online ahead of print.PMID: 40193585

 

  1. Synthetic Data in Healthcare and Drug Development: Definitions, Regulatory Frameworks, Issues. Pasculli G, Virgolin M, Myles P, Vidovszky A, Fisher C, Biasin E, Mourby M, Pappalardo F, D'Amico S, Torchia M, Chebykin A, Carbone V, Emili L, Roeshammar D.CPT Pharmacometrics Syst Pharmacol. 2025 Apr 7. doi: 10.1002/psp4.70021. Online ahead of print.PMID: 40193292 Free article.

 

  1. Outcomes associated with large loop excision of the cervical transformation zone in women 60-64 years of age: A population-based register study from Denmark. Erdal JL, Serizawa RR, Rebolj M, Schroll JB.Acta Obstet Gynecol Scand. 2025 Apr 7. doi: 10.1111/aogs.15111. Online ahead of print.PMID: 40193289

 

  1. Comparative Clinical Practice of Juvenile Idiopathic Arthritis and Rheumatoid Arthritis in Adolescents and Young Adults: A Retrospective Cohort Study Using Japanese Health Insurance Claims Data (2016-2020). Miyamae T, Sakai R, Inoue Y, Kato D, Inoue E, Hirano T, Izawa K, Kishida D, Matsushita M, Mitsunaga K, Mori M, Narazaki H, Nishikomori R, Shimizu M, Sugihara T, Sumitomo S, Tanaka T, Yamazaki S, Yamaji K, Yokogawa N, Yoshifuji H, Tanaka E, Harigai M.Mod Rheumatol. 2025 Apr 7:roaf035. doi: 10.1093/mr/roaf035. Online ahead of print.PMID: 40193103

 

  1. Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase®. Crescioli G, Lombardi N, Arzenton E, Luxi N, Fumagalli S, Bonaiuti R, Cacini C, Mannaioni G, Trifirò G, Moretti U, Vannacci A.Aging Clin Exp Res. 2025 Apr 7;37(1):120. doi: 10.1007/s40520-025-03025-4.PMID: 40192996 Free PMC article.

 

  1. Validation of an Administrative Claims-based Line of Therapy Algorithm for Women with Ovarian Cancer Using Medical Chart Review. Simmons D, White J, Walker V, Blank SV, Munley J, McLaurin K.Adv Ther. 2025 Apr 7. doi: 10.1007/s12325-025-03174-y. Online ahead of print.PMID: 40192966

 

  1. A scoping review of OMOP CDM adoption for cancer research using real world data. Wang L, Wen A, Fu S, Ruan X, Huang M, Li R, Lu Q, Lyu H, Williams AE, Liu H.NPJ Digit Med. 2025 Apr 7;8(1):189. doi: 10.1038/s41746-025-01581-7.PMID: 40189628 Free PMC article.

 

  1. Effect of intra-articular corticosteroid injections for knee osteoarthritis on the rates of subsequent knee replacement and post-operative outcomes: a national cohort study of England. Hawley S, Prats-Uribe A, Matharu GS, Delmestri A, Prieto-Alhambra D, Judge A, Whitehouse MR.BMC Med. 2025 Apr 7;23(1):195. doi: 10.1186/s12916-025-04000-6.PMID: 40189536 Free PMC article.

 

  1. All-cause healthcare resource utilization and costs among community-managed adults with long-COVID in France, 2020-2023. Yang J, Tamberou C, Arnee E, Squara PA, Boukhlal A, Nguyen JL, Volkman HR, Fiévez S, Lepoutre-Bourguet M, Ren J, Ben Romdhane H, Crépey P, Robineau O.J Med Econ. 2025 Dec;28(1):535-543. doi: 10.1080/13696998.2025.2485626. Epub 2025 Apr 8.PMID: 40162934 

 

  1. The Effectiveness of Risankizumab as Induction Therapy for Crohn's Disease: Data From the Sicilian Network for Inflammatory Bowel Diseases. Macaluso FS, Renna S, Fries W, Viola A, Cappello M, Salerno IA, Mocciaro F, Scrivo B, Giangreco E, Ferracane C, Minissale MG, Distefano ME, Tortorella V, Termini A, Bertoncello L, Orlando A. Inflamm Bowel Dis. 2025 Apr 10;31(4):1178-1181. doi: 10.1093/ibd/izae248.PMID: 39460746